检索结果 - Takumi Yamaji
- Showing 1 - 2 results of 2
-
1
Calreticulin mutant mice develop essential thrombocythemia that is ameliorated by the JAK inhibitor ruxolitinib 由 Kotaro Shide, Takuro Kameda, Takumi Yamaji, Masaaki Sekine, Naomi Inada, Ayako Kamiunten, Keiichi Akizuki, Kenichi Nakamura, Tomonori Hidaka, Yoko Kubuki, Haruko Shimoda, Akira Kitanaka, Arata Honda, Akira Sawaguchi, H Abe, Tadashi Miike, Hisayoshi Iwakiri, Yoshihiro Tahara, Mitsue Sueta, Satoru Hasuike, Shojiro Yamamoto, Kenji Nagata, Kazuya Shimoda
出版 2016Artigo -
2
Loss of TET2 has dual roles in murine myeloproliferative neoplasms: disease sustainer and disease accelerator 由 Takuro Kameda, Kotaro Shide, Takumi Yamaji, Ayako Kamiunten, Masaaki Sekine, Yasuhiro Taniguchi, Tomonori Hidaka, Yoko Kubuki, Haruko Shimoda, Kousuke Marutsuka, Goro Sashida, Kazumasa Aoyama, Makoto Yoshimitsu, Taku Harada, Hiroo Abe, Tadashi Miike, Hisayoshi Iwakiri, Yoshihiro Tahara, Mitsue Sueta, Shojiro Yamamoto, Satoru Hasuike, Kenji Nagata, Atsushi Iwama, Akira Kitanaka, Kazuya Shimoda
出版 2014Artigo
相关主题
Biology
Bone marrow
Cancer research
Haematopoiesis
Immunology
Myelofibrosis
Stem cell
Calreticulin
Cell biology
Cytokine
Endoplasmic reticulum
Essential thrombocythemia
Genetics
Internal medicine
Janus kinase
Janus kinase 2
Leukocytosis
Medicine
Megakaryocyte
Myeloid
Myeloproliferative neoplasm
Platelet
Polycythemia vera
Ruxolitinib
STAT5
Signal transduction
Thrombocytosis
Thrombopoietin
Thrombopoietin receptor
Transplantation